Latest article
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
/cloudfront-us-east-1.images.arcpublishing.com/gray/RUQJKG5G4NGKRGPCILENI4HGUE.jpg "Ft. Riley to require COVID-19 vaccines for entry to most on-post health facilities"){kind=small}
Ft. Riley to require COVID-19 vaccines for entry to most on-post health facilities
FORT RILEY, Kan. (WIBW) - Fort Riley requires that guests of all fitness centers with the exception of one post be fully vaccinated...
5 Magnificence necessities you could add to your wardrobe earlier than the monsoon season...
During the month of September, the monsoon season is slowly coming to an end. Soon the scorching sun will shine...